World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 12 July 2021
Main ID:  ChiCTR1800018340
Date of registration: 2018-09-12
Prospective Registration: Yes
Primary sponsor: Department of Radiology, West China Second Hospital, Sichuan University
Public title: Clinical study for cardiac MRI in evaluating early myocardial lesions in patients with muscular dystrophy
Scientific title: Clinical study for cardiac MRI in evaluating early myocardial lesions in patients with muscular dystrophy
Date of first enrolment: 2018-09-12
Target sample size: Target condition:200;Difficult condition:30
Recruitment status: Recruiting
URL:  http://www.chictr.org.cn/showproj.aspx?proj=29770
Study type:  Diagnostic test
Study design:  Sequential  
Phase:  0
Countries of recruitment
China
Contacts
Name: Yingkun Guo   
Address:  20 Third Section of Renmin Road South, Wuhou District, Chengdu, Sichuan, China
Telephone: +86 18980006572
Email: gykpanda@163.com
Affiliation:  Department of Radiology, West China Second Hospital, Sichuan University
Name: Hui Liu   
Address:  20 Third Section of Renmin Road South, Wuhou District, Chengdu, Sichuan, China
Telephone: +86 18582548552
Email: liuhuiimage@qq.com
Affiliation:  Department of Radiology, West China Second Hospital, Sichuan University
Key inclusion & exclusion criteria
Inclusion criteria: patients Diagnosed with muscular dystrophy by genome sequencing, muscle biopsy, and clinically relevant symptoms.
Exclusion criteria: MRI examination contraindications, claustrophobia, contrast allergy, severe renal insufficiency (serum creatinine clearance >120 mmol/L), severe cardiac insufficiency (NYHA-IV grade), frequent atrial fibrillation, thyroid dysfunction.

Age minimum: 4
Age maximum: 18
Gender: Male
Health Condition(s) or Problem(s) studied
Muscular dystrophy
Intervention(s)
Gold Standard:Genomic sequencing, muscle biopsy;Index test:Myocardial strain, T1/T2mapping value, late delayed enhancement (LGE), myocardial first pass perfusion;
Primary Outcome(s)
Myocardial delayed enhancement;Myocardial tissue stress;Myocardial perfusion;
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
The Ministry of education's new world talent support program
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 28/07/2018
Contact:
Mina
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history